NCT06562595Completed
What is the Optimal Training Model for Cervical Awareness?
Source: ClinicalTrials.gov · Last updated 20 May 2025
Brief summary (registry, in English)
Cervical cancer represents the fourth most prevalent malignant disease and the fourth leading cause of mortality among women on a global scale. Despite screening and preventive vaccination efforts, cervical cancer remains a significant cause of morbidity and mortality in low- and middle-income countries.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 400 (actual)
- First submitted
- 19 Aug 2024
- Start date
- 15 Aug 2024
- Primary completion date
- 15 Sept 2024
- Lead sponsor
- Izmir City Hospital
- Diseases
- Cervical cancer
- NCT number
- NCT06562595
What you commit to
- Study type: Interventional
- Participants enrolled: 400
- From 15 Aug 2024 to the primary completion date, 15 Sept 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Under 18 and over 40
- Not being a healthcare worker
- Not having enough mental capacity
- Having a visual or auditory disability
- Patients who did not volunteer to participate in the study
Who the study is looking for
- Being over 18 and under 40
- Female doctors, female nurses and female health technicians
- Working in our hospital
- Having sufficient mental capacity
- Not having a visual or auditory disability
- Volunteering to participate in the study
Age in the registry: 18 years to - · Sex: Female · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Izmir City Hospital Coordinator of this site? Confirm its status | Izmir | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.